Results 161 to 170 of about 9,884 (215)

LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC. [PDF]

open access: yesFuture Oncol
Machiels JP   +19 more
europepmc   +1 more source

Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced <i>ALK</i>-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers. [PDF]

open access: yesJCO Precis Oncol
Miao EA   +22 more
europepmc   +1 more source

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions. [PDF]

open access: yesJCO Precis Oncol
Patil T   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy